Back

Left atrial appendage closure in patients with atrial fibrillation and haemodialysis: outcomes from an international, multicentric registry

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: stroke - left atrial appendage closure Left Atrial Appendage Closure EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Lukas Urbanek

Cardioangiologisches Centrum Bethanien, Frankfurt (Germany)

7 More presentations in this session

Presentation thumbnail
Standalone transcatheter left atrial appendage closure or combined with cryoballoon pulmonary vein isolation
Doctor G. Fassini (Milan, IT)
Abstract Slides
Presentation thumbnail
Association of brain infarcts and cardiac autonomic dysfunction using entropy functions in patients with atrial fibrillation
Professor C. Meyer-Zurn (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Management of peri-device leaks after left atrial appendage closure using endovascular coils and/or amplatzer plugs and radiofrequency ablation
Doctor A. Maan (Toledo, US)
Abstract Slides Video
Presentation thumbnail
Left atrial appendage clipping during hybrid atrial fibrillation ablation: a very long-term, single-center experience
Doctor S. Mouram (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
A novel score to predict left atrial appendage thrombus and sludge in patients with persistent atrial fibrillation on chronic anticoagulants
Doctor L. Rampa (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: stroke - left atrial appendage closure

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Clinical and procedural outcomes of the percutaneous LAA closure in atrial fibrillation patients with high clinical and bleeding risk. Insight from the multi-center LAIT (LAmbre ITalian) registry
thumbnail
Congress Presentation
Anticoagulation patterns in haemodialysis patients - how do we anticoagulate in the absence of indications?
thumbnail
Congress Presentation
Direct oral anticoagulants exhibit lower risks of mortality and bleeding compared to vitamin-k antagonists in atrial fibrillation patients on chronic hemodialysis: a meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources